Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Affymetrix Inc.

Aug 2007
Affymetrix Inc. of Santa Clara, Calif., has announced that it has begun a collaboration with the University of Nijmegen in the Netherlands, the University of Tübingen in Germany and the NHS Regional Genetics Laboratory in Birmingham, UK, to investigate mental retardation in children. The partners will use the company’s microarray technology to search for mutations, copy number variants and loss of heterozygosity in subjects’ genomes. The institutions hope that the information gathered will help them better understand the causes of congenital abnormalities and retardation.

In other news, the Affymetrix Clinical Services Laboratory signed a co-marketing agreement with Docro Inc. of Seymour, Conn. The companies will assist clients in gaining FDA approval and clearance for in vitro diagnostic biomarker technologies. Validation and regulatory clinical trial resources and services available to customers of the laboratory will include protocol design, patient recruitment and clinical sample procurement.

Affymetrix Inc.Biophotonicsmicroarray technologyNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.